ANVISA registration

Teste Rápido de SARS-CoV-2 GlobalX

Registration 82568320012. CORONAVÍRUS

Registration details

Registration number82568320012
Application number25351076400202501
Technical nameCORONAVÍRUS
Risk classIII
Published on04/08/2025
ValidityValid until 04/08/2035

Registration holder

Legal nameGLOBALX PHARMA LTDA.
CNPJ41.775.241/0001-90

Manufacturer

  • ZHEJIANG ORIENT GENE BIOTECH CO., LTD. CHINA, REPÚBLICA POPULAR

Other registrations held by GLOBALX PHARMA LTDA.view all

Teste rápido em cassete de HIV 1.2

82568320001

Teste rápido em cassete de Sífilis

82568320002

Teste Rápido em Cassete de HBsAg

82568320003

Teste Rapido em Cassete de HCV

82568320004

Teste Rapido em Cassete de HIV 1.2 e Sífilis GlobalX

82568320005

Teste Rápido em Cassete de HBsAg GlobalX OG

82568320006

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist